Definium Therapeutics, Inc. (NasdaqGS: DFTX)
Health Care · Pharmaceuticals · US
$36.20
-1.90% today · +195.2% 1Y
Definium Therapeutics, Inc. (NasdaqGS: DFTX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.96B and employs 106 people.
Over the last twelve months the share price has gained 195.2%, trading between 10.46 and 49.70.
Tweenvest scores Definium Therapeutics, Inc. across four factors: quality 38/100, value 58/100. Its strongest factor is value.
DFTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.96B
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -3.48
- Dividend yield
- —
- Beta (5Y)
- 2.19
- 52-week high
- $49.70
- 52-week low
- $10.46
- Avg volume (3M)
- —
- Shares outstanding
- 134.37M
- Employees
- 106
- Next earnings
- —
About Definium Therapeutics, Inc.
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.
- ISIN
- CA24477V1058
- Listed since
- Nov 15, 2016
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Gland Pharma LimitedNSEI: GLAND | $5.22B | Rs3,061.80 | +6.52% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd.SZSE: 002294 | $5.12B | CN¥30.93 | +0.88% |
| Ipca Laboratories LimitedNSEI: IPCALAB | $5.02B | Rs1,915.40 | -1.43% |
| Beijing Tongrentang Co., LtdSHSE: 600085 | $4.97B | CN¥24.28 | +2.27% |
| Humanwell Healthcare (Group) Co.,Ltd.SHSE: 600079 | $4.69B | CN¥19.23 | +0.31% |
| Hanmi Pharm. Co., Ltd.KOSE: A128940 | $4.54B | ₩480,500.00 | -5.04% |
| Sumitomo Pharma Co., Ltd.TSE: 4506 | $4.51B | ¥1,591.50 | -1.36% |
| Hikma Pharmaceuticals PLCLSE: HIK | $4.46B | £16.31 | +1.18% |
Figures last refreshed Oct 11, 2026.